Tainted Drug May Still Be in U.S. Almost Decade After Deaths

Heparin tainted with unauthorized Chinese-made ingredients may be on the market in the U.S. and the Food and Drug Administration hasn’t moved swiftly enough to prevent it, according to a congressional probe nearly a decade after hundreds of deaths were linked to sullied batches of the blood-thinning drug.

This possible contamination is different from the...

Tainted Drug May Still Be in U.S. Almost Decade After Deaths Continue reading…

Volkswagen’s Quality Issues Widen With Latest Recalls

Volkswagen AG, still struggling to reach a deal with U.S. environmental authorities to fix nearly 600,000 tainted diesel-powered cars, could also be facing wider quality issues across a broad range of models in addition to its emissions-cheating scandal.

Read more.

Takata Puts Worst-Case Airbag Recall Costs at $24 Billion

Takata Corp., the supplier behind the auto industry’s biggest recall ever, estimated that a comprehensive callback of its airbag inflators would total about 2.7 trillion yen ($24 billion), according to a person familiar with the matter. The shares plunged to a record low.

The worst-case recall scenario would involve 287.5 million airbag inflators, said the...

Takata Puts Worst-Case Airbag Recall Costs at $24 Billion Continue reading…

Nearly All U.S. Doctors ‘Overprescribe’ Addictive Narcotic Painkillers: Survey

When American doctors give their patients narcotic painkillers, 99 percent of them hand out prescriptions that exceed the federally recommended three-day dosage limit, new research suggests.

And some doctors exceeded that limit by a lot: Nearly one-quarter gave out month-long dosages, despite the fact that research has shown that a month's use of prescription narcotic...

Nearly All U.S. Doctors ‘Overprescribe’ Addictive Narcotic Painkillers: Survey Continue reading…

Scope maker Olympus sought price hike amid superbug outbreak

Soon after doctors at UCLA's Ronald Reagan Medical Center traced deadly infections to tainted medical scopes last year, they pressed the device maker to lend them replacements.

But Olympus Corp. refused. Instead, the Tokyo company offered to sell UCLA 35 new scopes for $1.2 million — a 28% increase in price from what it charged...

Scope maker Olympus sought price hike amid superbug outbreak Continue reading…

Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds

A ProPublica analysis has found for the first time that doctors who receive payments from the medical industry do indeed tend to prescribe drugs differently than their colleagues who don’t. And the more money they receive, on average, the more brand-name medications they prescribe.

We matched records on payments from pharmaceutical and medical device makers...

Now There’s Proof: Docs Who Get Company Cash Tend to Prescribe More Brand-Name Meds Continue reading…